Should Infliximab be Used as an Adjuvant to IVIG in the Treatment of Children With Kawasaki Disease Who Are at High Risk for Resistance to Conventional Therapy?

被引：0
|
作者：
Shelby Davies
Gabrielle Gold-von Simson
机构：
[1] New York University School of Medicine,
来源：
Pediatric Cardiology | 2013年 / 34卷
关键词：
Vasculitis; Infliximab; Kawasaki Disease; Artery Aneurysm; IVIG Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1756 / 1756
相关论文
共 27 条
  • [1] Should Infliximab be Used as an Adjuvant to IVIG in the Treatment of Children With Kawasaki Disease Who Are at High Risk for Resistance to Conventional Therapy?
    Davies, Shelby
    Gold-von Simson, Gabrielle
    PEDIATRIC CARDIOLOGY, 2013, 34 (07) : 1756 - 1756
  • [2] Adaptation of Infliximab Therapy for Gamma Globulin Treatment Resistance Kawasaki Disease
    Hoshiai, Minako
    Katsumata, Nobuyuki
    Hasebe, Yohei
    Koizumi, Keiichi
    Toda, Takako
    Kise, Hiroaki
    Sugita, Kanji
    CIRCULATION, 2015, 131
  • [3] Adaptation of Infliximab Therapy for Gamma Globulin Treatment Resistance Kawasaki Disease
    Hoshiai, Minako
    Katsumata, Nobuyuki
    Hasebe, Yohei
    Koizumi, Keiichi
    Toda, Takako
    Kise, Hiroaki
    Sugita, Kanji
    CIRCULATION, 2015, 131
  • [4] Safety and Feasibility of Infliximab Therapy in Children With Kawasaki Disease Who Received Live Vaccinations
    Ohnishi, Yuji
    Okada, Seigo
    Kawakami-Miyake, Akiko
    Furuta, Takashi
    Fukano, Reiji
    Yasudo, Hiroki
    Shimokawa, Mototsugu
    Hasegawa, Shunji
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2022, 41 (09) : E388 - E392
  • [5] Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone, Pei-Ni
    Anderson, Marsha S.
    Mulvahill, Matthew J.
    Heizer, Heather
    Glode, Mary P.
    Dominguez, Samuel R.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (10) : 976 - 980
  • [6] The risk of hospitalization for respiratory tract infection (RTI) in children who are treated with high-dose IVIG in Kawasaki Disease:a nationwide population-based matched cohort study
    Lei, Wei-Te
    Lin, Chien-Yu
    Kao, Yu-Hsuan
    Lee, Cheng-Hung
    Lin, Chao-Hau
    Shyur, Shyh-Dar
    Yang, Kuender-Der
    Chen, Jian-Han
    PEERJ, 2018, 6
  • [7] Efficacy and Limitation of Infliximab Treatment for Children with Kawasaki Disease Intractable to Intravenous Immunoglobulin Therapy: Report of an Open-label Case Series
    Mori, Masaaki
    Imagawa, Tomoyuki
    Hara, Ryoki
    Kikuchi, Masako
    Hara, Takuma
    Nozawa, Tomo
    Miyamae, Takako
    Yokota, Shumpei
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (04) : 864 - 867
  • [8] Methylprednisolone pulse and prednisolone for intensification of primary treatment in Kawasaki disease patients at high risk of treatment resistance: a multicenter prospective cohort study
    Miura, Masaru
    Miyata, Koichi
    Kaneko, Tetsuji
    Akahoshi, Shogo
    Morikawa, Yoshihiko
    Matsushima, Takahiro
    Sakakibara, Hiroshi
    Kobayashi, Tohru
    Nakamura, Takahiro
    Takahashi, Tsutomu
    Nakazawa, Maki
    Shibata, Akimichi
    Yamagishi, Hiroyuki
    EUROPEAN JOURNAL OF PEDIATRICS, 2024, 183 (10) : 4265 - 4274
  • [9] Low mid-upper arm circumference identifies children with a high risk of death who should be the priority target for treatment
    Briend A.
    Alvarez J.-L.
    Avril N.
    Bahwere P.
    Bailey J.
    Berkley J.A.
    Binns P.
    Blackwell N.
    Dale N.
    Deconinck H.
    Delchevalerie P.
    Dent N.
    Gallagher M.
    Guerrero S.
    Hanson K.
    Kerac M.
    Manary M.
    Mwangome M.K.
    Myatt M.
    Phelan K.P.Q.
    Pietzsch S.
    Ubach N.S.
    Shepherd S.
    Van Der Kam S.
    Vargas A.
    Whitney S.
    BMC Nutrition, 2 (1)
  • [10] TREATMENT OF RECURRENT HIGH RISK NEUROBLASTOMA IN CHILDREN WHO ACHIEVED COMPLETE REMISSION AFTER FIRST LINE THERAPY
    Malis, J.
    Cyprova, S.
    Svojgr, K.
    Jerabkova, V.
    Taborska, K.
    Malinova, B.
    Pycha, K.
    Vicha, A.
    Sedlacek, P.
    Stary, J.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 110 - 110
123